Exhibit 107
Calculation of Filing Fee Tables
424(b)(5)
(Form Type)
Syndax Pharmaceuticals, Inc.
(Exact Name of Registrant as Specified in its Charter)
Table 1: Newly Registered and Carry Forward Securities
Security Type | Security Class Title | Fee Calculation or Carry Forward Rule | Amount Registered | Proposed Maximum Offering Price Per Share | Maximum Aggregate Offering Price (1) | Fee Rate | Amount of Registration Fee | Carry Forward Form Type | Carry Forward File Number | Carry Forward Initial effective date | Filing Fee Previously Paid In Connection with Securities Forward | |||||||||||||
Newly Registered Securities | ||||||||||||||||||||||||
Fees to Be Paid | Equity | Common Stock, $0.0001 par value per share | 457(o) | $200,000,000 | — | $200,000,000 | 0.00011020 | $22,040 | ||||||||||||||||
Fees Previously Paid | ||||||||||||||||||||||||
Carry Forward Securities | ||||||||||||||||||||||||
Carry Forward Securities | ||||||||||||||||||||||||
Total Offering Amounts | $200,000,000 | $22,040 | ||||||||||||||||||||||
Total Fees Previously Paid | — | |||||||||||||||||||||||
Total Fee Offsets | $5,423.39 | |||||||||||||||||||||||
Net Fee Due | $16,616.61 |
Table 2: Fee Offset Claims and Sources
Registrant or Filer Name | Form or Filing Type | File Number | Initial Filing Date | Filing Date | Fee Offset Claimed | Security Type Associated with Fee Offset Claimed | Security Associated with Fee Offset Claimed | Unsold Securities Associated with Fee Offset Claimed | Unsold Aggregate Offering Amount Associated with Fee Offset Claimed | Fee Paid with Fee Offset Source | ||||||||||||
Rule 457(b) and 0-11(a)(2) | ||||||||||||||||||||||
Fee Offset Claims | ||||||||||||||||||||||
Fee Offset Sources | ||||||||||||||||||||||
Rule 457(p) | ||||||||||||||||||||||
Fee Offset Claims | Syndax Pharmaceuticals, Inc. | S-3 ASR | 333-254661 | March 24, 2021 | $5,423.39 (2) | Equity | Common Stock, par value $0.001 per share | N/A | $49,710,253.37 | |||||||||||||
Fee Offset Sources | Syndax Pharmaceuticals, Inc. | S-3 ASR | 333-254661 | March 24, 2021 | $5,423.39 (2) |
(1) | The proposed maximum aggregate offering price is being used to calculate the registration fee pursuant to Rule 457(o) under the Securities Act of 1933, as amended. |
(2) | The registrant previously paid a registration fee of $7,496 in connection with the offering of shares of our common stock having an aggregate offering price of up to $75,000,000 pursuant to a sales agreement prospectus under an automatic shelf registration statement on Form S-3ASR (File No. 333-254661), originally filed with the Securities and Exchange Commission on March 24, 2021. As of the date hereof, shares of common stock having a maximum aggregate offering price of $49,710,253.37 remain unsold under the sales agreement prospectus (the offering of which unsold securities has been terminated). Pursuant to Rule 457(p) under the Securities Act, we are partially offsetting the registration fee of $22,040 due in connection with the sales agreement prospectus by the amount that was previously paid. Accordingly, the registrant is paying the registration fee due of $22,040, less the $5,423.39 that was previously paid, or $16,616.61. |